ASCEND BY NTHRYS
Research Abroad Products

CRISPR Project Topics

Browse all focused areas across all project categories under this field.

Showing 85–96 of 200 project topics
Cell Delivery Service for Base-Prime Editor Complexes
A contract manufacturing service that delivers optimized base and prime editor ribonucleoprotein complexes to target cells using proprietary nanoparticle and viral vector technologies. Generates revenue through per-delivery fees and multi-year manufacturing agreements with clinical-stage biotech partners.
CRISPR Base & Prime Editing Commercial Products Click to view more details →
Base Editor Protein Engineering Commercial Custom Service
A specialized protein engineering service that designs and produces enhanced base editor enzymes with improved catalytic activity and reduced toxicity for commercial clients. Delivers high-value custom development fees and exclusive IP licensing arrangements with pharmaceutical companies.
CRISPR Base & Prime Editing Commercial Products Click to view more details →
Prime Editor Dosage Optimization Analytics Platform
A data analytics platform that models and predicts optimal prime editor dosing regimens based on target tissue, delivery method, and desired editing efficiency for clinical trials. Monetizes through subscription licensing and performance-based royalties tied to client therapeutic approvals.
CRISPR Base & Prime Editing Commercial Products Click to view more details →
Base Editor Safety Assessment Regulatory Compliance Suite
A comprehensive commercial software suite that bundles assays, reporting tools, and regulatory documentation templates for base editor safety validation required by FDA and EMA approval pathways. Provides recurring license revenue and consulting service opportunities for GLP-certified testing.
CRISPR Base & Prime Editing Commercial Products Click to view more details →
Programmable RNA-Protein Library Commercial Screening Service
A high-throughput screening service offering curated libraries of prime editor components to identify optimal combinations for specific disease targets and delivery routes. Generates revenue through per-screen fees, reagent sales, and downstream licensing of validated component combinations.
CRISPR Base & Prime Editing Commercial Products Click to view more details →
Base-Prime Editor Patent Landscape Intelligence Commercial Platform
A subscription-based intelligence platform that tracks, analyzes, and visualizes patent landscapes for base and prime editing technologies to support commercial freedom-to-operate assessments. Monetizes through enterprise licensing subscriptions and strategic consulting services for biotech and pharma in-licensing teams.
CRISPR Base & Prime Editing Commercial Products Click to view more details →
CRISPR Patent Landscape Intelligence SaaS Platform
A comprehensive SaaS platform that aggregates and analyzes CRISPR patent filings, claims, and litigation data across jurisdictions in real-time. Enables biotech companies to reduce patent infringement risk, identify licensing opportunities, and accelerate market entry with data-driven IP strategies.
CRISPR Regulatory & IP Strategy Platforms Click to view more details →
Off-Target Effects Prediction and Mitigation Toolset
A computational software suite that predicts potential off-target CRISPR activity before clinical trials and recommends optimized guide RNA sequences to minimize unintended genome edits. Reduces regulatory burden, accelerates FDA approval timelines, and commands premium pricing in the precision medicine sector.
CRISPR Regulatory & IP Strategy Platforms Click to view more details →
CRISPR Regulatory Compliance and Documentation Automation
An enterprise automation platform that generates IND applications, manufacturing protocols, and quality control documentation required by FDA and EMA for CRISPR therapeutics. Reduces time-to-filing by 60 percent and positions clients as market-ready, creating recurring subscription revenue from biotech firms.
CRISPR Regulatory & IP Strategy Platforms Click to view more details →
IP Due Diligence and Freedom-to-Operate Analysis Engine
A specialized consulting platform offering algorithmic freedom-to-operate clearance reports and patent landscaping for CRISPR-based product development strategies. Generates high-margin advisory revenue by reducing investor and partner acquisition risk in licensing negotiations and M&A transactions.
CRISPR Regulatory & IP Strategy Platforms Click to view more details →
CRISPR Licensing Marketplace and Deal Negotiation Platform
A digital B2B marketplace connecting CRISPR intellectual property owners with licensees, featuring automated royalty calculators and contract templating for rapid deal closure. Monetizes through transaction fees, subscription tiers, and premium legal templates, capturing value across biotech licensing ecosystems.
CRISPR Regulatory & IP Strategy Platforms Click to view more details →
Adaptive CRISPR Variant Tracking and Resistance Monitoring
A cloud-based surveillance platform monitoring emerging CRISPR-resistant pathogen variants and automatically updating therapeutic design recommendations for therapeutic developers. Provides continuous SaaS revenue while establishing the company as essential infrastructure for real-time precision medicine delivery.
CRISPR Regulatory & IP Strategy Platforms Click to view more details →